Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
August 28, 2008
 
Industry Categories  
News by Country  
News by MSA  
Todays News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
Close Move
All Press Releases for January 18, 2007 Subscribe to this News Feed     Subscribe to this Podcast Feed  
 

Drug Importation Legislation Can Save Money, Lives and Maybe Even Medicare D

Bipartisan drug importation legislation recently introduced in the U.S. Senate and House can offer Americans a legal means of accessing safe and affordable medications from Canada. Canadian online pharmacies support the mail-order provision of the legislation but warn that bulk wholesale trade of drugs is not sustainable or practical.

Winnipeg, Canada (PRWEB) January 18, 2007 -- Senators Byron Dorgan (D- N.D.) and Olympia Snowe (R- ME) along with Reps. Rahm Emanuel (D-IL) and Jo Ann Emerson (R-MO) have re-introduced companion legislation in both houses of Congress aimed at facilitating importation of FDA approved medications from Canada and other countries. The Pharmaceutical Market Access and Drug Safety Act (S. 242/H.R. 380) intends to permit Americans to purchase prescription medications by mail from registered Canadian pharmacies for personal use and eventually allow licensed U.S. pharmacies and wholesalers to import wholesale medications from several designated countries in bulk. The bill brings an essential certification of safety and regulation by requiring FDA inspections of Canadian pharmacies and supply chain integrity through pedigree verification. It has also been given full endorsement by the AARP on behalf of its 38 million members.

pillbottlecreative.jpg

The chances of Canada facilitating the trade of massive quantities of drugs on the wholesale market are slim to none.
Licensed Canadian online pharmacies like Rx Care Canada have reliably dispensed medications to American patients for 5 years via the mail and welcome the opportunity to service a government-regulated program. Canadian pharmacies have proven that for many under or uninsured Americans, mail-order prescriptions are safe, affordable and convenient with savings that range from 30-86% off retail prices. However, many suppliers warn that the bulk importation or wholesale component of the bill is unsustainable and beyond the functional capacity of the Canadian pharmaceutical market.

"The Canadian market can easily meet the demand for mail-order prescription drugs because it services a limited uninsured demographic. But to expect Canada to fill the shelves of pharmacies and wholesalers across the U.S. is unrealistic and not likely to be acceptable to the Canadian government," says William Skubovius, President & COO of Rx Care Canada (www.rxcarecanada.com). "The chances of Canada facilitating the trade of massive quantities of drugs on the wholesale market are slim to none."

Most industry experts concur that the Canadian government is sure to respond precipitously with a ban on bulk exports should the legislation become enacted. There is also serious doubt about whether other countries, in Europe for example, would tolerate large-scale export of their drugs to the U.S. Furthermore, profit taking by wholesalers and retail pharmacies will certainly mitigate most of the savings to patients.

"Very little of the savings from bulk importation would end up being passed on to the consumer. Whereas, mail-order would preserve low prices for consumers by cutting out the middleman," adds Skubovius.

In fact, savings from Canada are so substantial that they compete well and in many cases surpass the discounts from the Medicare D prescription drug program for seniors. This may account for why many seniors that enrolled in Medicare D have returned to RxCareCanada.com in recent months.

"Higher premiums, more limited formulary coverage and an even bigger doughnut hole in 2007 make Canadian medications an excellent alternative or addition to Medicare D plans," says Skubovius.

"Passing drug importation legislation could be a perfect plug for the doughnut hole while helping millions of younger Americans who lack health insurance."

Rx Care Canada Pharmacy is licensed by the Manitoba Pharmaceutical Association (IPS license # 32690) and has been safely dispensing medications to American patients for 5 years. All Canadian drugs are regulated by Health Canada and dispensed by licensed pharmacists.

Media Contact:
William R Skubovius
Ph. 1-800-381-3594
Website: www.RxCareCanada.com

###

See the original story at: http://www.prweb.com/releases/2007/01/prweb497857.htm

Post Comment:
Trackback URL: http://ca.prweb.com/pingpr.php/U2luZy1TdW1tLVRoaXItTG92ZS1NYWduLVplcm8=

Technorati Tags

Bookmark -  Del.icio.us | Digg | Furl It | Spurl | RawSugar | Simpy | Shadows | Blink It | My Web


Other Releases by this Member
OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareIt

Share The News

Submit this press release easily to any of these major bookmarking and social media sites.

CONTACT INFORMATION
William Skubovius
RxCare Canada Pharmacy
1-800-381-3594
Email us Here
ATTACHED FILES

Special Offer
Click here to view a special coupon offer from RxCareCanada.com

RxCare Canada Pharmacy Profile
Click here to view a pharmacy profile of RxCare Canada

RxCare Canada Pharmacy

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these releases. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright